Found: 12
Select item for more details and to access through your institution.
Real-world evidence of triplet therapy efficacy in patients with metastatic castration-sensitive prostate cancer: a Japanese multicenter study.
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 11, p. 1208, doi. 10.1093/jjco/hyae098
- By:
- Publication type:
- Article
Pagetoid spread of urothelial carcinoma controlled without resection.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Clear identification of the rare solitary external iliac lymph node metastasis of testicular cancer by using indocyanine green fluorescence guidance.
- Published in:
- IJU Case Reports, 2021, v. 4, n. 3, p. 163, doi. 10.1002/iju5.12273
- By:
- Publication type:
- Article
Clinical benefit of continuing pembrolizumab treatment beyond progression in patients with metastatic urothelial carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 1, p. 229, doi. 10.1007/s00262-021-02980-x
- By:
- Publication type:
- Article
No survival benefit found after extended treatment with docetaxel for patients with castration‐resistant prostate cancer.
- Published in:
- Prostate, 2019, v. 79, n. 14, p. 1604, doi. 10.1002/pros.23884
- By:
- Publication type:
- Article
Novel "double‐pulling" technique for neobladder‐urethral anastomosis in laparoscopic radical cystectomy.
- Published in:
- International Journal of Urology, 2020, v. 27, n. 9, p. 822, doi. 10.1111/iju.14301
- By:
- Publication type:
- Article
Comparison of the Immunotherapy Response Evaluation Criteria in Solid Tumours (iRECIST) with RECIST for capturing treatment response of patients with metastatic urothelial carcinoma treated with pembrolizumab.
- Published in:
- BJU International, 2021, v. 127, n. 1, p. 90, doi. 10.1111/bju.15176
- By:
- Publication type:
- Article
Combination of docetaxel versus nonsteroidal antiandrogen with androgen deprivation therapy for high-volume metastatic hormone-sensitive prostate cancer: a propensity score-matched analysis.
- Published in:
- World Journal of Urology, 2023, v. 41, n. 8, p. 2051, doi. 10.1007/s00345-022-04030-2
- By:
- Publication type:
- Article
Impact of Dose-Effect in Smoking on the Effectiveness of Pembrolizumab in Patients with Metastatic Urothelial Carcinoma.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 2, p. 189, doi. 10.1007/s11523-020-00786-y
- By:
- Publication type:
- Article
Docetaxel versus abiraterone for metastatic hormone‐sensitive prostate cancer with focus on efficacy of sequential therapy.
- Published in:
- Prostate, 2023, v. 83, n. 6, p. 563, doi. 10.1002/pros.24488
- By:
- Publication type:
- Article
Does castration status affect docetaxel‐related adverse events? :Identification of risk factors for docetaxel‐related adverse events in metastatic prostate cancer.
- Published in:
- Prostate, 2022, v. 82, n. 14, p. 1322, doi. 10.1002/pros.24406
- By:
- Publication type:
- Article
Abiraterone acetate versus nonsteroidal antiandrogen with androgen deprivation therapy for high‐risk metastatic hormone‐sensitive prostate cancer.
- Published in:
- Prostate, 2022, v. 82, n. 1, p. 3, doi. 10.1002/pros.24243
- By:
- Publication type:
- Article